Results 151 to 160 of about 28,051 (225)

Camlipixant: A New Hope for Refractory Chronic Cough? [PDF]

Am J Respir Crit Care Med
Satia I, Mazzone SB.
europepmc   +1 more source

Granulomatosis with Polyangiitis Presenting as Refractory Chronic Cough, Manifesting by Massive Alveolar Haemorrhage - A Rare Case Report. [PDF]

Int Med Case Rep J, 2021
Al Zaidi A, Al Zahrani AM, Alzahrani Z.
europepmc   +1 more source

Efficacy of morphine on cough in patients with repeat expansions of <i>RFC1</i> and refractory chronic cough. [PDF]

ERJ Open Res
Guilleminault L, Chazelas P, Magdelaine C, Villeneuve T, Lia AS, Magy L.   +5 more
europepmc   +1 more source

An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough. [PDF]

ERJ Open Res, 2021
Abdulqawi R, Satia I, Holt KJ, Dockry R, Sen S, Smith JA.   +5 more
europepmc   +1 more source

Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy. [PDF]

Lung, 2021
Slovarp LJ, Jetté ME, Gillespie AI, Reynolds JE, Barkmeier-Kraemer JM.   +4 more
europepmc   +1 more source

Sodium channel blockers as add-on treatment for unexplained refractory chronic cough: a case report and review. [PDF]

Front Med (Lausanne)
Butnariu I, Balan MF, Zaharia DC, Bobocea R, Mitrică IA, Moraru A, Dionisie V, Lăptoiu VI, Antonescu-Ghelmez D, Antonescu F.   +9 more
europepmc   +1 more source

Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study. [PDF]

Eur Respir J, 2021
Morice A, Smith JA, McGarvey L, Birring SS, Parker SM, Turner A, Hummel T, Gashaw I, Fels L, Klein S, Francke K, Friedrich C.   +11 more
europepmc   +1 more source

The Past, Present, and Future Care for Refractory Chronic Cough in Children and Adults. [PDF]

J Clin Med
Weinberger M, Anbar RD, Buettner D.
europepmc   +1 more source

Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial. [PDF]

Eur Respir J
Diab N, Brister D, Kum E, Wahab M, Hassan W, Beaudin S, Obminski C, Wattie J, Wiltshire L, Howie K, Killian K, Holt K, Sehmi R, Gauvreau GM, Smith JA, O'Byrne PM, Satia I.   +16 more
europepmc   +1 more source

Reply to Rui and Chen: Initial Success: Camlipixant in Refractory Chronic Cough. [PDF]

Am J Respir Crit Care Med
Smith JA.
europepmc   +1 more source